Author Correction: Tocilizumab versus sarilumab among adults hospitalised with COVID-19: target trial emulation across England and Scotland.
Journal: Nature communications
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Zheng B, Kurdi A, Amstutz A, et al. (2026). "Author Correction: Tocilizumab versus sarilumab among adults hospitalised with COVID-19: target trial emulation across England and Scotland.". Nature communications. https://doi.org/10.1038/s41467-026-78874-2